Literature DB >> 15970608

The prevalence and clinical characteristics of cystic fibrosis in South Asian Canadian immigrants.

M Mei-Zahav1, P Durie, J Zielenski, M Solomon, E Tullis, L-C Tsui, M Corey.   

Abstract

BACKGROUND: Cystic fibrosis (CF) is considered to be rare among individuals from the Indian subcontinent. Furthermore, affected individuals are reported to experience a more severe clinical course. AIMS: It was hypothesised that CF is under diagnosed in people of South Asian origin and therefore the prevalence may be higher than previously estimated.
METHODS: The prevalence of CF in the South Asian and in the general population living in the same geographic region (Metropolitan Toronto) were compared between 1996 and 2001. Population data were obtained from the Canadian census survey. CF phenotype and genotype data were obtained from the Toronto CF database.
RESULTS: Among 381 patients with CF, 15 were of South Asian descent. The age related prevalence of CF among the South Asian and general populations was: 0-14 years, 1:9200 versus 1:6600; 15-24 years, 1:13,200 versus 1:7600; older than 25 years, 1:56,600 versus 1:12,400. Age at diagnosis, duration and severity of symptoms at diagnosis, current nutritional status, and FEV(1) were similar in the two groups. While not significant, FEV1 tended to be lower (48% versus 57% predicted) among adult South Asians, compared to the general CF population. Also, the percentage with pancreatic sufficiency was higher (27% versus 16%) and the frequency of DeltaF508 allele was lower (50% versus 65.1%).
CONCLUSIONS: These data suggest that the prevalence and natural history of CF in South Asians is similar to that among individuals of European origin. The relatively lower prevalence among older South Asians may reflect an improving recognition of CF in this ethnic subgroup.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15970608      PMCID: PMC1720469          DOI: 10.1136/adc.2003.042614

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  13 in total

1.  Is the spectrum of mutations in Indian patients with cystic fibrosis different?

Authors:  M Kabra; S K Kabra; M Ghosh; A Khanna; S Arora; P S Menon; I C Verma; A Wallace
Journal:  Am J Med Genet       Date:  2000-07-17

2.  CFTR mutation detection by multiplex heteroduplex (mHET) analysis on MDE gel.

Authors:  Julian Zielenski; Isabel Aznarez; Tuncer Onay; John Tzounzouris; Danuta Markiewicz; Lap-Chee Tsui
Journal:  Methods Mol Med       Date:  2002

3.  Cystic fibrosis: postmortem report on two cases.

Authors:  M L Prasad; A Misra; M Mathur; D K Gupta
Journal:  Indian Pediatr       Date:  1990-05       Impact factor: 1.411

4.  Genetic analysis of cystic fibrosis in Pakistan: a preliminary report.

Authors:  Z A Bhutta; T Moattar; U Shah
Journal:  J Pak Med Assoc       Date:  2000-07       Impact factor: 0.781

5.  Cystic fibrosis in Asian Indians.

Authors:  C A Powers; E M Potter; H U Wessel; J D Lloyd-Still
Journal:  Arch Pediatr Adolesc Med       Date:  1996-05

6.  Cystic fibrosis of pancreas in India.

Authors:  C R Reddy; C Sita Devi; A M Anees; D Prasantha Murthy; G Eswar Reddy
Journal:  J Trop Med Hyg       Date:  1970-03

7.  Mucoviscidosis of the lung. Report of a case.

Authors:  O N Bhakoo; R Kumar; B N Walia
Journal:  Indian J Pediatr       Date:  1968-04       Impact factor: 1.967

8.  Delta F508 testing of the DNA bank of the Royal Manchester Children's Hospital.

Authors:  M J Schwarz; M Super; C Wallis; P Beighton; C Newton; L E Heptinstall; C Summers; A Markham; G Hambleton; K W Webb
Journal:  Hum Genet       Date:  1990-09       Impact factor: 4.132

9.  Cystic fibrosis in North Indian children.

Authors:  Meenu Singh; Rajendra Prasad; Lata Kumar
Journal:  Indian J Pediatr       Date:  2002-07       Impact factor: 1.967

10.  Cystic fibrosis in Asians.

Authors:  I M Bowler; E J Estlin; J M Littlewood
Journal:  Arch Dis Child       Date:  1993-01       Impact factor: 3.791

View more
  7 in total

1.  Understanding the population structure of North American patients with cystic fibrosis.

Authors:  W Li; L Sun; M Corey; F Zou; S Lee; A L Cojocaru; C Taylor; S M Blackman; A Stephenson; A J Sandford; R Dorfman; M L Drumm; G R Cutting; M R Knowles; P Durie; F A Wright; L J Strug
Journal:  Clin Genet       Date:  2011-02       Impact factor: 4.438

2.  Molecular basis of cystic fibrosis disease: an Indian perspective.

Authors:  R Prasad; H Sharma; G Kaur
Journal:  Indian J Clin Biochem       Date:  2010-11-19

3.  Serious fungal infections in Pakistan.

Authors:  K Jabeen; J Farooqi; S Mirza; D Denning; A Zafar
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-02-04       Impact factor: 3.267

4.  Delays in diagnosing cystic fibrosis: can we find ways to diagnose it earlier?

Authors:  Michelle Steinraths; Hilary D Vallance; A George F Davidson
Journal:  Can Fam Physician       Date:  2008-06       Impact factor: 3.275

5.  An empirical estimate of carrier frequencies for 400+ causal Mendelian variants: results from an ethnically diverse clinical sample of 23,453 individuals.

Authors:  Gabriel A Lazarin; Imran S Haque; Shivani Nazareth; Kevin Iori; A Scott Patterson; Jessica L Jacobson; John R Marshall; William K Seltzer; Pasquale Patrizio; Eric A Evans; Balaji S Srinivasan
Journal:  Genet Med       Date:  2012-09-13       Impact factor: 8.822

6.  Phenotypic spectrum and genetic heterogeneity of cystic fibrosis in Sri Lanka.

Authors:  Neluwa Liyanage Ruwan Indika; Dinesha Maduri Vidanapathirana; Hewa Warawitage Dilanthi; Grace Angeline Malarnangai Kularatnam; Nambage Dona Priyani Dhammika Chandrasiri; Eresha Jasinge
Journal:  BMC Med Genet       Date:  2019-05-24       Impact factor: 2.103

7.  NGS-based expanded carrier screening for genetic disorders in North Indian population reveals unexpected results - a pilot study.

Authors:  Kanika Singh; Sunita Bijarnia-Mahay; V L Ramprasad; Ratna Dua Puri; Sandhya Nair; Sheetal Sharda; Renu Saxena; Sudha Kohli; Samarth Kulshreshtha; Indrani Ganguli; Kanwal Gujral; Ishwar C Verma
Journal:  BMC Med Genet       Date:  2020-11-02       Impact factor: 2.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.